Search research articles
Contact Us
Filters
Showing results (1-10 of 359) with videos related to
Page
of 36
Sort By:
Zeitschrift Fur Kardiologie
|
March 19, 2003
The role of decision-analytic models in the prevention, diagnosis and treatment of coronary heart disease
Uwe Siebert
GMS Health Technology Assessment
|
February 4, 2011
Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
Uwe Siebert
German Medical Science : GMS E-Journal
|
August 14, 2009
Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
Uwe Siebert, Gaby Sroczynski, , et al.
Nature Reviews. Gastroenterology & Hepatology
|
August 21, 2013
Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C
Gaby Sroczynski, Uwe Siebert
European Journal of Public Health
|
July 24, 2010
Do women with cancer have better survival as compared to men after adjusting for staging distribution?
Willi Oberaigner, Uwe Siebert
International Journal of Technology Assessment in Health Care
|
July 22, 2009
Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden
Ruth Schwarzer, Uwe Siebert
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
August 18, 2009
Markov processes for the prediction of aircraft noise effects on sleep
Mathias Basner, Uwe Siebert
Acta Oncologica (Stockholm, Sweden)
|
August 29, 2009
Are survival rates for Tyrol published in the Eurocare studies biased?
Willi Oberaigner, Uwe Siebert
International Journal of Technology Assessment in Health Care
|
March 2, 2005
Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security
Uwe Siebert, Gaby Sroczynski, , et al.
European Journal of Epidemiology
|
August 19, 2018
To stop or not to stop: a value of information view
Uwe Siebert, Lára R Hallsson
Page
of 36
Search research articles
Search
Showing results (1-10 of 359) with videos related to
Sort By:
Page
of 36
Zeitschrift Fur Kardiologie
|
March 19, 2003
The role of decision-analytic models in the prevention, diagnosis and treatment of coronary heart disease
Uwe Siebert
GMS Health Technology Assessment
|
February 4, 2011
Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
Uwe Siebert
German Medical Science : GMS E-Journal
|
August 14, 2009
Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
Uwe Siebert, Gaby Sroczynski, , et al.
Nature Reviews. Gastroenterology & Hepatology
|
August 21, 2013
Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C
Gaby Sroczynski, Uwe Siebert
European Journal of Public Health
|
July 24, 2010
Do women with cancer have better survival as compared to men after adjusting for staging distribution?
Willi Oberaigner, Uwe Siebert
International Journal of Technology Assessment in Health Care
|
July 22, 2009
Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden
Ruth Schwarzer, Uwe Siebert
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
August 18, 2009
Markov processes for the prediction of aircraft noise effects on sleep
Mathias Basner, Uwe Siebert
Acta Oncologica (Stockholm, Sweden)
|
August 29, 2009
Are survival rates for Tyrol published in the Eurocare studies biased?
Willi Oberaigner, Uwe Siebert
International Journal of Technology Assessment in Health Care
|
March 2, 2005
Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security
Uwe Siebert, Gaby Sroczynski, , et al.
European Journal of Epidemiology
|
August 19, 2018
To stop or not to stop: a value of information view
Uwe Siebert, Lára R Hallsson
Page
of 36